secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001104659-24-084645
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sagimet Biosciences expands board to 9, appoints Jennifer Jarrett and Dr. Anne Phillips as directors
--------------------------------------------------------------------------------

- Board expanded from 7 to 9 directors; appointments effective August 1, 2024.
- Jennifer Jarrett, COO of Arcus Biosciences, joins Audit Committee; Dr. Anne Phillips, former Novo Nordisk SVP, joins Nominating & Governance Committee.
- Each new director receives initial stock option grant of $300,000 vesting over 3 years under 2023 Stock Option Plan.
- Both are independent under Nasdaq rules; no related party transactions disclosed.
- Jarrett serves on boards of Syndax, Zura Bio, others; Phillips on boards of Trevena, Barinthus, vTv Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465924084645/0001104659-24-084645-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465924084645/tm2420572d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-084645

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer